American Association for Cancer Research

MEG Election Results

Congratulations to Jo L. Freudenheim, Ph.D., MEG Chairperson-Elect 2014-2015

Thank you to the MEG Nominating Committee for its efforts to ensure that two appropriate candidates were selected to stand for election. Dr. Freudenheim will assume the office of chairperson-elect at the AACR Annual Meeting 2014, April 5-9, 2014, in San Diego, CA.

Jo L. FreudenheimJo L. Freudenheim, Ph.D.
Distinguished Professor
Dept. of Preventive and Social Medicine
State University of New York at Buffalo
Buffalo, NY

Other Current Positions:
Adjunct Professor, Roswell Park Cancer Institute

Previous Positions of Relevance:
Department Chair, State University of New York at Buffalo

Education and Training:

Ph.D. in Nutritional Sciences
University of Wisconsin-Madison, 1986

Postdoctoral Fellowship in Cancer Epidemiology
State University of Buffalo at New York, 1987-1988

Lutheran General Hospital, Park Ridge, IL, 1977

Awards and Honors:

Distinguished Postdoc Mentor Award, Office of Postdoctoral Scholars, The Graduate School, University at Buffalo

Outstanding Researcher, School of Public Health and Health Professions, University at Buffalo

Lydia Jane Roberts Memorial Lecturer, University of Puerto Rico, San Juan, Puerto Rico, 2007

SUNY Chancellor’s Award for Excellence in Research and Scholarship

University at Buffalo Distinguished Professor

Distinguished Faculty Award, Institute for Research on Women and Gender, University at Buffalo

University at Buffalo Exceptional Scholar Program, Sustained Achievement Award

Research Career Development Award, National Institutes of Health (NIH)

Experienced Faculty Travel Award, NYS-UUP

National Institute of Biogerontology, Madison, Wisconsin

Kemper Knapp Bequest

Achievement Award, Ann Arbor Dietetic Association, Ann Arbor, MI


Member, American Association for Cancer Research (AACR), 1996-present

Member, Molecular Epidemiology (MEG) Working Group of the AACR, 1999-present

Member, Molecular Epidemiology (MEG) Working Group Steering Committee of the AACR, 2010-2012

Member, Molecular Epidemiology (MEG) Nominating Committee, 2013-2014

Member, Women in Cancer Research (WICR) Association Group of the AACR, 1997-present

Member, Board of Scientific Counselors, National Cancer Institute (NCI), 2007-2012

Chair and Member, EPIC Study Section, NCI, 2004-2006; and 1997-2002

Chair, Working Group on Nutritional Epidemiology, American Society for Nutritional Sciences (ASNS), 1990-1993

Editorial Positions:

Senior Editor, Cancer Epidemiology, Biomarkers & Prevention, 2011-present

Editorial Board Member, Cancer Causes and Control, 1999-present

Research Interests:

My research is focused on an integrated understanding of breast cancer epidemiology at the molecular, tissue, individual and population levels. With a background in nutrition and epidemiology, much of my research has focused on nutritional factors in relation to carcinogenesis, working toward an understanding of mechanism. In addition, I have an interest in early life exposures as they relate to cancer in adulthood. I have led interdisciplinary teams working toward a clearer comprehension of breast carcinogenesis, examining genetic factors and other molecular markers of exposure including methylation in relation to breast cancer outcomes, and to molecular characteristics of breast tumors.

Proposed Goals:

The Molecular Epidemiology Group (MEG), now approximately 15 years old, has grown in size and in its contribution to the AACR. It serves an important role providing a locus for bringing together epidemiology with other scientists working at the molecular level. As the research in our field changes, MEG continues to take leadership, providing insight to researchers about new developments and new directions; this role needs to continue and to be emphasized. As MEG chairperson-elect, I will work to expand the opportunities for active involvement of members. There is a continuing need to expand the membership of MEG, promoting active involvement of associate members, reaching investigators outside of the United States and providing more opportunities for integration of basic, clinical and population sciences. I see the need to continue to interface and expand interaction with other organizations with similar aims, such as ASPO and the newly-formed Molecular Pathological Epidemiology (MPE) group. Further, I see a role for MEG in leadership in the discussion of issues affecting those doing molecular epidemiology, such as regarding the recently proposed genomic data sharing policy for sharing other data as well as genomic data. MEG is uniquely poised for all of these initiatives.